Trial intelligence / Profile preview

Gel-One for Pain After ACL Reconstruction (HEALR)

NCT03429140Phase 1Completed

Start
Apr 2017
Primary completion
Jun 2019
Modality
Hydrogel Systems
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in anterior cruciate ligament injury comparing Gel-One Arm with Placebo Arm (2 arms). Primary endpoint: Knee Injury and Osteoarthritis Outcome Score at 12 months. Started Apr 2017; status: completed.

02

Drugs

hyaluronic acid hydrogel
03

Conditions

anterior cruciate ligament injury

Beyond the preview

Go deeper on NCT03429140.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03429140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call